AI-powered cross-level cross-species omics data integration to elucidate mechanisms of EL
AI-powered cross-level cross-species omics data integration to elucidate mechanisms of EL
批准号:
10729946
负责人:
Alicia Melendez
金额:
$45.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2025-07-31
关键词:
AddressAffectAgeAgingAlgorithmsAlzheimer&aposs DiseaseBindingBiologicalBiological MarkersBiological ModelsBiologyCaenorhabditis elegansChemicalsCollaborationsDNADataData AnalysesData ReportingData SetDimensionsDiseaseDrug ModelingsDrug usageFoundationsGeneticGenomicsGenotypeHealthHumanIndividualKnowledgeLaboratoriesLearningLongevityMachine LearningMathematicsMethodologyMethodsModelingMolecularMolecular TargetMultiomic DataNaturePathway interactionsPerformancePharmacologic SubstancePharmacologyPhasePhenotypePhysiologicalProteinsProteomicsRNAReproducibilityResourcesSystemWorkbiological systemsbiomarker identificationcancer genomicsdata harmonizationdata integrationdata miningdata modelingdata resourcedeep learningdiverse datadrug discoverydruggable targetepigenomicsfeature selectiongenetic informationgenome-widegenomic dataheterogenous datahigh dimensionalityhigh throughput technologyimprovedin vivo Modelinnovationlearning strategymachine learning algorithmmachine learning modelmetabolomicsmodel organismmouse modelmultilevel analysismultimodalitymultiple omicsnetwork modelsnew therapeutic targetnovelnovel markerpharmacologicphenomicspredictive modelingscreeningsuccesstargeted agenttraittranscriptomicstransfer learningtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
It is a formidable task to identify the molecular causes of complicated traits such as exceptional longevity (EL).
The majority of machine learning algorithms generate mathematical correlations between genotypes and
phenotypes, but may fail to infer physiologically significant causes. A mechanistic understanding of how
individual molecular components work together in a system and how the system is affected and adapted to the
molecular change requires knowledge of molecular interactions across all biological levels, from DNAs to
RNAs to proteins to metabolites to organismal phenotypes. By integrating multi-omics data, recent approaches
in multi-modal machine learning and multi-layer network model promise to address this deficiency. However,
existing machine learning approaches are hampered by high-dimensionality, non-uniformity, numerous
confounders, and biological differences in multi-omics data across data resources, data domains, and species
as well as lack of interpretability due to the black-box nature of machine learning models. We will develop a
transformative deep learning framework to address challenges for multi-omics data integration and predictive
modeling of causal genotype-EL associations. This project is established on our substantial preliminary results,
successes in systems pharmacology for Alzheimer's disease drug discovery and using C. elegans as disease
and aging models, and close collaborations between experimental and computational laboratories. We shall
overcome several obstacles in order to discover the molecular mechanisms of EL. We will develop and
validate novel algorithms to 1) harmonize non-uniform data sets by removing environmental and biological
confounding factors (e.g., age, species, etc.) and technical biases (e.g., batch effect), 2) explicitly model the
biological information flow from DNAs to RNAs to proteins to metabolites to organismal phenotypes, and 3)
determine causal genetic factors and molecular interactions underlying EL. Specifically, we will: (1) develop
MuLGIT, a causal deep learning-powered cross-layer multi-omics harmonization and integration framework
that follows the central dogma of biology for deciphering the molecular interplays underlying EL; (2) develop a
transfer learning method PATH-AE for cross-species omics data integration and modeling for elucidating
evolutionarily conserved and species-specific molecular determinants of EL; (3) identify molecular targets and
pharmaceutical agents of EL by merging new methodologies for multi-omics data integration with state-of-the-
art methods for chemical genomics and perturbation genomics; and (4) experimentally validate computational
predictions using C. elegans models. Completion of this project will allow us to identify novel biomarkers,
druggable targets, and pharmacological agents associated with remarkable lifespan (EL).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of autophagy and retromer genes in GLP-1/Notch signaling
-
批准号:9171257
-
项目类别:
-
资助金额:$46.2万
-
财政年份:2012
-
负责人:Alicia Melendez
-
依托单位:
Role of autophagy and retromer genes in GLP-1/Notch signaling
-
批准号:8367474
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2012
-
负责人:Alicia Melendez
-
依托单位:
海外基金